Ben R. Bronstein, M.D.

Ben R. Bronstein, M.D.

DirectoratAldeyra Therapeutics· In proxies 2023–2025

Ben R. Bronstein, M.D. sits on 3 public boards.

Boards1

  • Aldeyra TherapeuticsDirector · 14 yr on the boardIndependentAudit, Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Aldeyra TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -90%
  2. Intercept Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Kadmon HoldingsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?